A carregar...
Plasma Cannabinoid Pharmacokinetics following Controlled Oral Δ(9)-Tetrahydrocannabinol and Oromucosal Cannabis Extract Administration
BACKGROUND: Sativex(®), a cannabis extract oromucosal spray containing Δ(9)-tetrahydrocannabinol (THC) and cannabidiol (CBD), is currently in phase III trials as an adjunct to opioids for cancer pain treatment, and recently received United Kingdom approval for treatment of spasticity. There are indi...
Na minha lista:
Main Authors: | , , , , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
2010
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3717338/ https://ncbi.nlm.nih.gov/pubmed/21078841 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1373/clinchem.2010.152439 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|